# SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

> **NCT03778996** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sarcoma Oncology Research Center, LLC** · enrollment: 31 (actual)

## Conditions studied

- Sarcoma, Ewing
- Sarcoma

## Interventions

- **DRUG:** Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)

## Key facts

- **NCT ID:** NCT03778996
- **Lead sponsor:** Sarcoma Oncology Research Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-03
- **Primary completion:** 2027-12-19
- **Final completion:** 2028-03-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778996, "SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03778996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*